Ysios Capital, specializing in biotech investments, will invest $157 million in Engrail Therapeutics, joining a syndicate led by F-Prime Capital. Engrail, founded in 2019, focuses on...
The stock of the biotech group Evotec (WKN: 566480), based in Hamburg, stands out positively. The reason may be the fact that the company intends to...
Biotechnology is an exciting field that works with biology to develop new enhancements in medicine and science. Because of its broad reach, it comes as no...